3 results
Approved WMOCompleted
A better understanding on the individual response to different albuminuria lowering drugs and a better understanding why these drugs, of which some are developed for another indication, may help to tailor optimal therapy. Therefore in this study…
Approved WMOCompleted
PrimaryTo evaluate the long-term safety and tolerability of baricitinib in patients with SLE.
Approved WMOCompleted
To evaluate the effect of baricitinib 4-mg QD and background standard-of-care therapy compared with placebo and background standard-of-care therapy on SLE disease activity.